ES2010668B3 - Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina. - Google Patents

Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina.

Info

Publication number
ES2010668B3
ES2010668B3 ES86402703T ES86402703T ES2010668B3 ES 2010668 B3 ES2010668 B3 ES 2010668B3 ES 86402703 T ES86402703 T ES 86402703T ES 86402703 T ES86402703 T ES 86402703T ES 2010668 B3 ES2010668 B3 ES 2010668B3
Authority
ES
Spain
Prior art keywords
phenyl
procedure
preparation
tetrahydropyrimidine derivatives
tetrahydropyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES86402703T
Other languages
English (en)
Inventor
Louis Lafon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8518462A external-priority patent/FR2591592B1/fr
Priority claimed from FR8603644A external-priority patent/FR2595696B2/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Application granted granted Critical
Publication of ES2010668B3 publication Critical patent/ES2010668B3/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE LA 5-FENIL-1, 4, 5, 6-TETRAHIDROPIRIMIDINA DE FORMULA (I) EN LA CUAL X1 Y X2, IDENTICOS O DIFERENTES, SON CADA UNO, H, F, CL, BR O CF3 Y A ES UN GRUPO POLIHIDROPIRIMIDILO DE ESTRUCTURA (II) SE INDICAN CADA UNO DE LOS RADICALES QUE FORMAN PARTE DE LA ESTRUCTURA (II). ESTOS NUEVOS PRODUCTOS SON UTILES EN TERAPEUTICA COMO ANTIDEPRESIVOS Y/O SEDANTES.
ES86402703T 1985-12-13 1986-12-05 Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina. Expired ES2010668B3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8518462A FR2591592B1 (fr) 1985-12-13 1985-12-13 Derives de 5-phenyl-1,4,5,6-tetrahydropyrimidine, procede de preparation et utilisation en therapeutique
FR8603644A FR2595696B2 (fr) 1986-03-14 1986-03-14 Derives de 5-phenyl-1, 4, 5, 6-tetrahydropyrimidine, procede de preparation et utilisation en therapeutique

Publications (1)

Publication Number Publication Date
ES2010668B3 true ES2010668B3 (es) 1989-12-01

Family

ID=26224881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86402703T Expired ES2010668B3 (es) 1985-12-13 1986-12-05 Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina.

Country Status (11)

Country Link
US (1) US4774248A (es)
EP (1) EP0226511B1 (es)
JP (1) JPH0764827B2 (es)
AU (1) AU585105B2 (es)
CA (1) CA1273016A (es)
DE (1) DE3664768D1 (es)
DK (1) DK170043B1 (es)
ES (1) ES2010668B3 (es)
GR (1) GR3000200T3 (es)
IE (1) IE59330B1 (es)
PT (1) PT83922B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2536947Y2 (ja) * 1990-03-27 1997-05-28 日本電気株式会社 電歪効果素子
ZA9610738B (en) * 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
TW427978B (en) * 1996-02-03 2001-04-01 Hoffmann La Roche Tetrahydroisoquinoline derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001232A (en) * 1974-08-17 1977-01-04 Bayer Aktiengesellschaft Process for preparing 1-substituted 2-methyl-tetrahydropyrimidines
FI753673A7 (es) * 1975-01-15 1976-07-16 Merck & Co Inc
DE2751805A1 (de) * 1977-11-19 1979-05-23 Veba Chemie Ag Verfahren zur herstellung von blockierten polyisocyanaten
US4281126A (en) * 1978-01-30 1981-07-28 Petrolite Corporation N-Substituted 1,2,3,4-tetrahydropyrimidines, Hexahydropyrimidines and process for their preparation
DE3041834A1 (de) * 1980-11-06 1982-06-09 Bayer Ag, 5090 Leverkusen Neue amidine und amidin/isocyanat-addukte, verfahren zu ihrer herstellung und ihre verwendung als katalysatoren fuer die haertung von epoxidharzen
US4404302A (en) * 1982-05-27 1983-09-13 Ferro Corporation Acylated hindered hexahydropyrimidines and their use as light stabilizing agents

Also Published As

Publication number Publication date
IE863254L (en) 1987-06-13
AU6639586A (en) 1987-06-18
GR3000200T3 (en) 1990-12-31
US4774248A (en) 1988-09-27
JPS62187460A (ja) 1987-08-15
EP0226511B1 (fr) 1989-08-02
DK601386D0 (da) 1986-12-12
DK601386A (da) 1987-06-14
EP0226511A1 (fr) 1987-06-24
CA1273016A (en) 1990-08-21
DE3664768D1 (en) 1989-09-07
PT83922B (pt) 1989-06-30
DK170043B1 (da) 1995-05-08
JPH0764827B2 (ja) 1995-07-12
IE59330B1 (en) 1994-02-09
AU585105B2 (en) 1989-06-08
PT83922A (fr) 1987-01-01

Similar Documents

Publication Publication Date Title
ES2072779T3 (es) Derivados aminoacidos anfoteros.
ATE126232T1 (de) Neue derivate von a-nor-3-carboxysteroiden.
DE3779770D1 (de) Instandhaltung der verfuegbarkeit eines wiederanlauffaehigen datenbasissystems.
YU157191A (sh) Antagonisti receptora fibrinogena
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
ES2045152T3 (es) Derivados de lipidos, su preparacion y uso.
ES473818A1 (es) Procedimiento para preparar derivados de piperazina.
IT1038527B (it) Procedimento per la tintura di resine sintetiche poliuetaniche
ES479668A1 (es) Un procedimiento para la preparacion de nuevas 5-alquil- ciopirimidinas.
ES2010668B3 (es) Procedimiento de preparacion de derivados de 5-fenil-1,4,5,6-tetrahidropirimidina.
FI892222A0 (fi) Peptidalkoholer med antikoagulantverkan.
FR904239A (fr) Procédé de préparation d'interpolyamides synthétiques linéaires
FR2375239A1 (fr) Derives d'acide 7-amino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES2061530T3 (es) 9-amino-1,4-etano-1,2,3,4-tetrahidroacridina y compuestos afines, intermediarios y un procedimiento para la preparacion de los mismos y su uso como medicamentos.
IT1055074B (it) Idspositivo di fissaggio del tallone per attacchi di sicurezza dasci
ES2081447T3 (es) Sulfonil-fenil-beta-d-tioxilosidos, su procedimiento de preparacion y su empleo en terapeutica.
IT989916B (it) Procedimento per la preparazione di fosfiti tris 2 alogeno alchilici utili come additivi ignifuganti
ES8603825A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo piperidinopropanolico sustituido y sus sa- les de adicion acidas y amonicas cuaternarias
MX9303392A (es) Derivados de imidazo benzoxazin-1-ona substituidos y proceso para su preparacion.
ES2062223T3 (es) Derivados de imidazol, procedimiento para la preparacion de los mismos y agentes antiulcera que los contienen.
IT1038529B (it) Procedimento per la tintura di resine sintetiche poliuretaiche
DE3660959D1 (de) Benz-trisubstituted 2-aminotetralins
BE804768A (fr) Construction formee d'un reseau de poutres ainsi que d'elements maintenus par ce reseau